Literature DB >> 28821664

Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.

Philip D Fox1, Shane T Hentges2.   

Abstract

Activation of somatic μ-opioid receptors (MORs) in hypothalamic proopiomelanocortin (POMC) neurons leads to the activation of G-protein-coupled inward rectifier potassium (GIRK) channels and hyperpolarization, but in response to continued signaling MORs undergo acute desensitization resulting in robust reduction in the peak GIRK current after minutes of agonist exposure. We hypothesized that the attenuation of the GIRK current would lead to a recovery of neuronal excitability whereby desensitization of the receptor would lead to a new steady state of POMC neuron activity reflecting the sustained GIRK current observed after the initial decline from peak with continued agonist exposure. However, electrophysiologic recordings and GCaMP6f Ca2+ imaging in POMC neurons in mouse brain slices indicate that maximal inhibition of cellular activity by these measures can be maintained after the GIRK current declines. Blockade of the GIRK current by Ba2+ or Tertiapin-Q did not disrupt the sustained inhibition of Ca2+ transients in the continued presence of agonist, indicating the activation of an effector other than GIRK channels. Use of an irreversible MOR antagonist and Furchgott analysis revealed a low receptor reserve for the activation of GIRK channels but a >90% receptor reserve for the inhibition of Ca2+ events. Altogether, the data show that somatodendritic MORs in POMC neurons inhibit neuronal activity through at least two effectors with distinct levels of receptor reserve and that differentially reflect receptor desensitization. Thus, in POMC cells, the decline in the GIRK current during prolonged MOR agonist exposure does not reflect an increase in cellular activity as expected.SIGNIFICANCE STATEMENT Desensitization of the μ-opioid receptor (MOR) is thought to underlie the development of cellular tolerance to opiate therapy. The present studies focused on MOR desensitization in hypothalamic proopiomelanocortin (POMC) neurons as these neurons produce the endogenous opioid β-endorphin and are heavily regulated by opioids. Prolonged activation of somatic MORs in POMC neurons robustly inhibited action potential firing and Ca2+ activity despite desensitization of the MOR and reduced activation of a potassium current over the same time course. The data show that somatic MORs in POMC neurons couple to multiple effectors that have differential sensitivity to desensitization of the receptor. Thus, in these cells, the cellular consequence of MOR desensitization cannot be defined by the activity of a single effector system.
Copyright © 2017 the authors 0270-6474/17/378667-11$15.00/0.

Entities:  

Keywords:  GIRK; action potential; calcium imaging; electrophysiology; hypothalamus; receptor reserve

Mesh:

Substances:

Year:  2017        PMID: 28821664      PMCID: PMC5588460          DOI: 10.1523/JNEUROSCI.1030-17.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

Review 1.  Efficacy and ligand bias at the μ-opioid receptor.

Authors:  E Kelly
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

2.  Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons.

Authors:  Reagan L Pennock; Shane T Hentges
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

Review 3.  The opiomelanotropinergic neuronal and endocrine systems.

Authors:  T L O'Donohue; D M Dorsa
Journal:  Peptides       Date:  1982 May-Jun       Impact factor: 3.750

4.  Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.

Authors:  J H Brown; D Goldstein
Journal:  Mol Pharmacol       Date:  1986-12       Impact factor: 4.436

5.  Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.

Authors:  M Nowoczyn; N Marie; L Coulbault; M Hervault; A Davis; J L Hanouz; S Allouche
Journal:  Neuropharmacology       Date:  2013-06-21       Impact factor: 5.250

6.  Effect of the mu-opioid agonist DAMGO on medial basal hypothalamic neurons in beta-endorphin knockout mice.

Authors:  R M Slugg; M D Hayward; O K Ronnekleiv; M J Low; M J Kelly
Journal:  Neuroendocrinology       Date:  2000-10       Impact factor: 4.914

7.  Opioids act at mu-receptors to hyperpolarize arcuate neurons via an inwardly rectifying potassium conductance.

Authors:  M D Loose; M J Kelly
Journal:  Brain Res       Date:  1990-04-09       Impact factor: 3.252

8.  Relationship between receptor occupancy and response at striatal dopamine autoreceptors.

Authors:  E Meller; K Bohmaker; Y Namba; A J Friedhoff; M Goldstein
Journal:  Mol Pharmacol       Date:  1987-06       Impact factor: 4.436

Review 9.  The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence.

Authors:  Lene Martini; Jennifer L Whistler
Journal:  Curr Opin Neurobiol       Date:  2007-12-18       Impact factor: 6.627

Review 10.  Opioid receptor desensitization: mechanisms and its link to tolerance.

Authors:  Stéphane Allouche; Florence Noble; Nicolas Marie
Journal:  Front Pharmacol       Date:  2014-12-18       Impact factor: 5.810

View more
  7 in total

1.  GABAergic Inputs to POMC Neurons Originating from the Dorsomedial Hypothalamus Are Regulated by Energy State.

Authors:  Andrew R Rau; Shane T Hentges
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

2.  Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates.

Authors:  Zilong Wang; Changyu Jiang; Qianru He; Megumi Matsuda; Qingjian Han; Kaiyuan Wang; Sangsu Bang; Huiping Ding; Mei-Chuan Ko; Ru-Rong Ji
Journal:  Sci Transl Med       Date:  2020-02-19       Impact factor: 17.956

3.  μ-Opioid Receptor Activation Directly Modulates Intrinsically Photosensitive Retinal Ganglion Cells.

Authors:  Allison M Cleymaet; Shannon K Gallagher; Ryan E Tooker; Mikhail Y Lipin; Jordan M Renna; Puneet Sodhi; Daniel Berg; Andrew T E Hartwick; David M Berson; Jozsef Vigh
Journal:  Neuroscience       Date:  2019-04-11       Impact factor: 3.590

4.  Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin.

Authors:  Marissa J Metz; Caitlin M Daimon; Shane T Hentges
Journal:  eNeuro       Date:  2021-06-16

5.  Roux-en-Y gastric bypass in rat reduces mu-opioid receptor levels in brain regions associated with stress and energy regulation.

Authors:  Matthew McGregor; John Hamilton; Andras Hajnal; Panayotis K Thanos
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

6.  Dopamine D4 Receptor Is a Regulator of Morphine-Induced Plasticity in the Rat Dorsal Striatum.

Authors:  Alicia Rivera; Diana Suárez-Boomgaard; Cristina Miguelez; Alejandra Valderrama-Carvajal; Jérôme Baufreton; Kirill Shumilov; Anne Taupignon; Belén Gago; M Ángeles Real
Journal:  Cells       Date:  2021-12-23       Impact factor: 6.600

Review 7.  Recent Progress in Opioid Research from an Electrophysiological Perspective.

Authors:  William T Birdsong; John T Williams
Journal:  Mol Pharmacol       Date:  2020-03-20       Impact factor: 4.436

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.